Pathway Name Avg Num Perturbations Total Perturbations Num Entities Min Mean Truth Max Mean Truth Min Mean Within Max Mean Within Min Mean Any Max Mean Within FOXM1 transcription factor network 218.0 11120.0 51.0 -0.03 0.762 1000.0 -1000.0 -0.067 -1000.0 Glypican 2 network 171.0 687.0 4.0 0.094 0.137 1000.0 -1000.0 0.019 -1000.0 Angiopoietin receptor Tie2-mediated signaling 141.0 12456.0 88.0 -0.569 0.11 1000.0 -1000.0 -0.052 -1000.0 Aurora B signaling 122.0 8224.0 67.0 -0.155 0.275 1000.0 -1000.0 -0.025 -1000.0 HIF-1-alpha transcription factor network 118.0 9040.0 76.0 -0.066 0.43 1000.0 -1000.0 -0.034 -1000.0 Signaling events mediated by the Hedgehog family 106.0 5522.0 52.0 -0.217 0.102 1000.0 -1000.0 -0.028 -1000.0 Endothelins 80.0 7685.0 96.0 -0.309 0.191 1000.0 -1000.0 -0.039 -1000.0 PLK1 signaling events 71.0 6068.0 85.0 -0.048 0.192 1000.0 -1000.0 -0.021 -1000.0 Aurora C signaling 67.0 474.0 7.0 -0.0 0.165 1000.0 -1000.0 -0.005 -1000.0 Signaling mediated by p38-alpha and p38-beta 65.0 2891.0 44.0 -0.102 0.021 1000.0 -1000.0 -0.018 -1000.0 Visual signal transduction: Cones 61.0 2349.0 38.0 -0.08 0.12 1000.0 -1000.0 -0.017 -1000.0 FOXA2 and FOXA3 transcription factor networks 60.0 2782.0 46.0 -0.201 0.154 1000.0 -1000.0 -0.061 -1000.0 Signaling events regulated by Ret tyrosine kinase 55.0 4560.0 82.0 -0.074 0.061 1000.0 -1000.0 -0.04 -1000.0 Fc-epsilon receptor I signaling in mast cells 53.0 5146.0 97.0 -0.093 0.021 1000.0 -1000.0 -0.035 -1000.0 RXR and RAR heterodimerization with other nuclear receptor 51.0 2682.0 52.0 -0.145 0.045 1000.0 -1000.0 -0.022 -1000.0 Osteopontin-mediated events 50.0 1917.0 38.0 -0.001 0.232 1000.0 -1000.0 -0.018 -1000.0 BMP receptor signaling 50.0 4108.0 81.0 -0.18 0.216 1000.0 -1000.0 -0.024 -1000.0 IL4-mediated signaling events 49.0 4548.0 91.0 -0.627 0.34 1000.0 -1000.0 -0.093 -1000.0 amb2 Integrin signaling 49.0 4057.0 82.0 -0.288 0.079 1000.0 -1000.0 -0.019 -1000.0 Ephrin B reverse signaling 46.0 2225.0 48.0 -0.074 0.076 1000.0 -1000.0 -0.028 -1000.0 Visual signal transduction: Rods 46.0 2420.0 52.0 -0.08 0.098 1000.0 -1000.0 -0.032 -1000.0 p75(NTR)-mediated signaling 39.0 4974.0 125.0 -0.15 0.131 1000.0 -1000.0 -0.043 -1000.0 Thromboxane A2 receptor signaling 37.0 3892.0 105.0 -0.121 0.07 1000.0 -1000.0 -0.032 -1000.0 IL23-mediated signaling events 37.0 2225.0 60.0 -0.203 0.027 1000.0 -1000.0 -0.066 -1000.0 Calcineurin-regulated NFAT-dependent transcription in lymphocytes 36.0 2499.0 68.0 -0.146 0.064 1000.0 -1000.0 -0.059 -1000.0 Syndecan-1-mediated signaling events 35.0 1195.0 34.0 -0.0 0.207 1000.0 -1000.0 -0.02 -1000.0 Neurotrophic factor-mediated Trk receptor signaling 34.0 4134.0 120.0 -0.163 0.143 1000.0 -1000.0 -0.041 -1000.0 LPA4-mediated signaling events 33.0 397.0 12.0 -0.072 -0.0 1000.0 -1000.0 -0.016 -1000.0 Arf6 signaling events 33.0 2064.0 62.0 -0.105 0.07 1000.0 -1000.0 -0.018 -1000.0 Integrins in angiogenesis 33.0 2799.0 84.0 -0.071 0.228 1000.0 -1000.0 -0.032 -1000.0 Canonical Wnt signaling pathway 33.0 1683.0 51.0 -0.205 0.097 1000.0 -1000.0 -0.026 -1000.0 TCGA08_retinoblastoma 33.0 267.0 8.0 -0.022 0.098 1000.0 -1000.0 -0.003 -1000.0 Presenilin action in Notch and Wnt signaling 32.0 1956.0 61.0 -0.206 0.097 1000.0 -1000.0 -0.027 -1000.0 Glucocorticoid receptor regulatory network 32.0 3740.0 114.0 -0.262 0.159 1000.0 -1000.0 -0.041 -1000.0 TCGA08_p53 32.0 227.0 7.0 -0.023 0.019 1000.0 -1000.0 -0.009 -1000.0 Aurora A signaling 31.0 1867.0 60.0 -0.028 0.182 1000.0 -1000.0 -0.015 -1000.0 IL6-mediated signaling events 31.0 2379.0 75.0 -0.149 0.051 1000.0 -1000.0 -0.034 -1000.0 Reelin signaling pathway 30.0 1725.0 56.0 -0.038 0.049 1000.0 -1000.0 -0.019 -1000.0 EGFR-dependent Endothelin signaling events 30.0 637.0 21.0 -0.027 0.07 1000.0 -1000.0 -0.029 -1000.0 HIF-2-alpha transcription factor network 29.0 1268.0 43.0 -0.131 0.137 1000.0 -1000.0 -0.031 -1000.0 Noncanonical Wnt signaling pathway 28.0 752.0 26.0 -0.043 0.038 1000.0 -1000.0 -0.022 -1000.0 Glypican 1 network 28.0 1353.0 48.0 -0.06 0.037 1000.0 -1000.0 -0.024 -1000.0 Effects of Botulinum toxin 27.0 703.0 26.0 -0.0 0.044 1000.0 -1000.0 -0.008 -1000.0 Wnt signaling 27.0 191.0 7.0 -0.021 0.038 1000.0 -1000.0 -0.0 -1000.0 Nongenotropic Androgen signaling 24.0 1269.0 52.0 -0.062 0.044 1000.0 -1000.0 -0.022 -1000.0 IL1-mediated signaling events 23.0 1426.0 62.0 -0.082 0.043 1000.0 -1000.0 -0.038 -1000.0 Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 23.0 775.0 33.0 -0.07 0.096 1000.0 -1000.0 -0.022 -1000.0 Nephrin/Neph1 signaling in the kidney podocyte 21.0 720.0 34.0 -0.036 0.061 1000.0 -1000.0 -0.026 -1000.0 ErbB4 signaling events 21.0 1506.0 69.0 -0.111 0.146 1000.0 -1000.0 -0.024 -1000.0 PDGFR-alpha signaling pathway 21.0 964.0 44.0 -0.188 0.039 1000.0 -1000.0 -0.033 -1000.0 FoxO family signaling 21.0 1356.0 64.0 0.0 0.191 1000.0 -1000.0 -0.051 -1000.0 LPA receptor mediated events 21.0 2174.0 102.0 -0.058 0.079 1000.0 -1000.0 -0.049 -1000.0 Syndecan-4-mediated signaling events 21.0 1436.0 67.0 -0.043 0.121 1000.0 -1000.0 -0.027 -1000.0 Regulation of Androgen receptor activity 21.0 1536.0 70.0 -0.144 0.127 1000.0 -1000.0 -0.031 -1000.0 Syndecan-2-mediated signaling events 20.0 1397.0 69.0 -0.047 0.053 1000.0 -1000.0 -0.024 -1000.0 Nectin adhesion pathway 20.0 1303.0 63.0 -0.046 0.051 1000.0 -1000.0 -0.037 -1000.0 FAS signaling pathway (CD95) 19.0 893.0 47.0 -0.235 0.034 1000.0 -1000.0 -0.021 -1000.0 EPHB forward signaling 19.0 1693.0 85.0 -0.032 0.084 1000.0 -1000.0 -0.04 -1000.0 Calcium signaling in the CD4+ TCR pathway 19.0 589.0 31.0 -0.039 0.03 1000.0 -1000.0 -0.032 -1000.0 Lissencephaly gene (LIS1) in neuronal migration and development 18.0 996.0 54.0 -0.034 0.102 1000.0 -1000.0 -0.027 -1000.0 Ceramide signaling pathway 18.0 1369.0 76.0 -0.019 0.07 1000.0 -1000.0 -0.022 -1000.0 Class IB PI3K non-lipid kinase events 18.0 54.0 3.0 -0.008 0.008 1000.0 -1000.0 -0.017 -1000.0 S1P4 pathway 18.0 474.0 25.0 -0.019 0.027 1000.0 -1000.0 -0.013 -1000.0 IL12-mediated signaling events 17.0 1501.0 87.0 -0.132 0.057 1000.0 -1000.0 -0.056 -1000.0 Signaling events mediated by PTP1B 17.0 1305.0 76.0 -0.056 0.071 1000.0 -1000.0 -0.033 -1000.0 S1P5 pathway 17.0 295.0 17.0 -0.016 0.021 1000.0 -1000.0 -0.002 -1000.0 Plasma membrane estrogen receptor signaling 17.0 1495.0 86.0 -0.061 0.057 1000.0 -1000.0 -0.031 -1000.0 Caspase cascade in apoptosis 16.0 1197.0 74.0 -0.03 0.086 1000.0 -1000.0 -0.027 -1000.0 Coregulation of Androgen receptor activity 16.0 1239.0 76.0 -0.057 0.096 1000.0 -1000.0 -0.02 -1000.0 PLK2 and PLK4 events 16.0 50.0 3.0 -0.007 0.036 1000.0 -1000.0 -0.014 -1000.0 Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 16.0 1369.0 85.0 -0.058 0.035 1000.0 -1000.0 -0.031 -1000.0 TCR signaling in naïve CD8+ T cells 16.0 1550.0 93.0 -0.041 0.034 1000.0 -1000.0 -0.035 -1000.0 ErbB2/ErbB3 signaling events 15.0 975.0 65.0 -0.049 0.03 1000.0 -1000.0 -0.066 -1000.0 BARD1 signaling events 15.0 864.0 57.0 -0.046 0.113 1000.0 -1000.0 -0.04 -1000.0 S1P1 pathway 14.0 537.0 36.0 -0.09 0.021 1000.0 -1000.0 -0.022 -1000.0 Signaling events mediated by VEGFR1 and VEGFR2 14.0 1854.0 125.0 -0.188 0.042 1000.0 -1000.0 -0.039 -1000.0 BCR signaling pathway 14.0 1458.0 99.0 -0.049 0.08 1000.0 -1000.0 -0.054 -1000.0 Signaling events mediated by Stem cell factor receptor (c-Kit) 14.0 1138.0 78.0 -0.038 0.023 1000.0 -1000.0 -0.036 -1000.0 Signaling events mediated by HDAC Class III 13.0 537.0 40.0 -0.06 0.061 1000.0 -1000.0 -0.035 -1000.0 Syndecan-3-mediated signaling events 13.0 469.0 35.0 -0.117 0.046 1000.0 -1000.0 -0.018 -1000.0 Regulation of p38-alpha and p38-beta 13.0 749.0 54.0 -0.036 0.06 1000.0 -1000.0 -0.037 -1000.0 IL27-mediated signaling events 12.0 643.0 51.0 -0.044 0.03 1000.0 -1000.0 -0.041 -1000.0 Signaling events mediated by PRL 11.0 385.0 34.0 -0.021 0.082 1000.0 -1000.0 -0.027 -1000.0 Class I PI3K signaling events 10.0 744.0 73.0 -0.033 0.06 1000.0 -1000.0 -0.021 -1000.0 Regulation of nuclear SMAD2/3 signaling 9.0 1235.0 136.0 -0.171 0.072 1000.0 -1000.0 -0.03 -1000.0 Ephrin A reverse signaling 9.0 63.0 7.0 -0.012 0.029 1000.0 -1000.0 -0.007 -1000.0 IL2 signaling events mediated by STAT5 9.0 218.0 22.0 -0.024 0.091 1000.0 -1000.0 -0.026 -1000.0 Insulin Pathway 9.0 669.0 74.0 -0.096 0.051 1000.0 -1000.0 -0.034 -1000.0 VEGFR1 specific signals 9.0 543.0 56.0 -0.188 0.047 1000.0 -1000.0 -0.022 -1000.0 PDGFR-beta signaling pathway 9.0 920.0 97.0 -0.032 0.052 1000.0 -1000.0 -0.039 -1000.0 JNK signaling in the CD4+ TCR pathway 8.0 149.0 17.0 -0.012 0.047 1000.0 -1000.0 -0.026 -1000.0 Cellular roles of Anthrax toxin 8.0 321.0 39.0 -0.031 0.027 1000.0 -1000.0 -0.016 -1000.0 Hedgehog signaling events mediated by Gli proteins 8.0 524.0 65.0 -0.137 0.048 1000.0 -1000.0 -0.035 -1000.0 mTOR signaling pathway 8.0 428.0 53.0 -0.057 0.025 1000.0 -1000.0 -0.038 -1000.0 IFN-gamma pathway 8.0 567.0 68.0 -0.028 0.063 1000.0 -1000.0 -0.035 -1000.0 Retinoic acid receptors-mediated signaling 8.0 493.0 58.0 -0.094 0.046 1000.0 -1000.0 -0.028 -1000.0 Stabilization and expansion of the E-cadherin adherens junction 8.0 632.0 74.0 -0.086 0.07 1000.0 -1000.0 -0.048 -1000.0 Ras signaling in the CD4+ TCR pathway 8.0 150.0 17.0 -0.004 0.031 1000.0 -1000.0 -0.01 -1000.0 Sphingosine 1-phosphate (S1P) pathway 7.0 196.0 28.0 -0.015 0.034 1000.0 -1000.0 -0.014 -1000.0 EPO signaling pathway 7.0 426.0 55.0 -0.025 0.046 1000.0 -1000.0 -0.027 -1000.0 ceramide signaling pathway 7.0 360.0 49.0 -0.007 0.029 1000.0 -1000.0 -0.026 -1000.0 Role of Calcineurin-dependent NFAT signaling in lymphocytes 7.0 602.0 83.0 -0.056 0.046 1000.0 -1000.0 -0.023 -1000.0 Regulation of Telomerase 7.0 776.0 102.0 -0.02 0.099 1000.0 -1000.0 -0.04 -1000.0 IL2 signaling events mediated by PI3K 6.0 353.0 58.0 -0.014 0.077 1000.0 -1000.0 -0.031 -1000.0 HIV-1 Nef: Negative effector of Fas and TNF-alpha 6.0 300.0 45.0 -0.015 0.051 1000.0 -1000.0 -0.03 -1000.0 TCGA08_rtk_signaling 6.0 157.0 26.0 -0.013 0.047 1000.0 -1000.0 -0.005 -1000.0 E-cadherin signaling in the nascent adherens junction 6.0 528.0 76.0 -0.03 0.051 1000.0 -1000.0 -0.039 -1000.0 Arf6 trafficking events 6.0 475.0 71.0 -0.037 0.039 1000.0 -1000.0 -0.031 -1000.0 IGF1 pathway 6.0 378.0 57.0 -0.031 0.048 1000.0 -1000.0 -0.027 -1000.0 E-cadherin signaling in keratinocytes 6.0 265.0 43.0 -0.015 0.039 1000.0 -1000.0 -0.022 -1000.0 p38 MAPK signaling pathway 6.0 295.0 44.0 -0.005 0.063 1000.0 -1000.0 -0.017 -1000.0 Signaling events mediated by HDAC Class I 5.0 552.0 104.0 -0.035 0.048 1000.0 -1000.0 -0.034 -1000.0 Signaling mediated by p38-gamma and p38-delta 5.0 89.0 15.0 -0.017 0.022 1000.0 -1000.0 -0.017 -1000.0 S1P3 pathway 5.0 225.0 42.0 -0.022 0.035 1000.0 -1000.0 -0.016 -1000.0 Signaling events mediated by HDAC Class II 4.0 355.0 75.0 -0.021 0.057 1000.0 -1000.0 -0.024 -1000.0 Circadian rhythm pathway 4.0 92.0 22.0 -0.004 0.046 1000.0 -1000.0 -0.02 -1000.0 Arf6 downstream pathway 4.0 195.0 43.0 -0.048 0.049 1000.0 -1000.0 -0.025 -1000.0 Class I PI3K signaling events mediated by Akt 4.0 282.0 68.0 -0.029 0.044 1000.0 -1000.0 -0.025 -1000.0 Canonical NF-kappaB pathway 2.0 101.0 39.0 -0.016 0.042 1000.0 -1000.0 -0.017 -1000.0 Insulin-mediated glucose transport 2.0 65.0 32.0 -0.015 0.038 1000.0 -1000.0 -0.024 -1000.0 Paxillin-independent events mediated by a4b1 and a4b7 2.0 100.0 37.0 -0.023 0.05 1000.0 -1000.0 -0.018 -1000.0 TRAIL signaling pathway 2.0 133.0 48.0 -0.017 0.046 1000.0 -1000.0 -0.018 -1000.0 Rapid glucocorticoid signaling 2.0 46.0 20.0 -0.008 0.026 1000.0 -1000.0 -0.01 -1000.0 Arf1 pathway 2.0 129.0 54.0 -0.008 0.034 1000.0 -1000.0 -0.015 -1000.0 Regulation of cytoplasmic and nuclear SMAD2/3 signaling 1.0 35.0 23.0 0.0 0.036 1000.0 -1000.0 -0.013 -1000.0 a4b1 and a4b7 Integrin signaling 1.0 7.0 5.0 0.02 0.03 1000.0 -1000.0 0.016 -1000.0 Paxillin-dependent events mediated by a4b1 1.0 62.0 36.0 -0.037 0.039 1000.0 -1000.0 -0.026 -1000.0 Atypical NF-kappaB pathway 1.0 49.0 31.0 -0.017 0.029 1000.0 -1000.0 -0.018 -1000.0 E-cadherin signaling events 1.0 6.0 5.0 0.019 0.039 1000.0 -1000.0 0.017 -1000.0 Sumoylation by RanBP2 regulates transcriptional repression 0.0 23.0 27.0 -0.018 0.045 1000.0 -1000.0 -0.028 -1000.0 Alternative NF-kappaB pathway 0.0 0.0 13.0 0.0 0.056 1000.0 -1000.0 0.0 -1000.0 Total 3410 200741 7203 -9.53803153524 10.6102834983 131000 -131000 -3.55760070486 -131000